These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9876226)

  • 1. Granulocyte/macrophage-colony stimulating factor in allergen-induced rhinitis: cellular localization, relation to tissue eosinophilia and influence of topical corticosteroid.
    Nouri-Aria KT; Masuyama K; Jacobson MR; Rak S; Lowhagen O; Schotman E; Hamid Q; Durham S
    Int Arch Allergy Immunol; 1998 Dec; 117(4):248-54. PubMed ID: 9876226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids.
    Masuyama K; Till SJ; Jacobson MR; Kamil A; Cameron L; Juliusson S; Lowhagen O; Kay AB; Hamid QA; Durham SR
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):610-7. PubMed ID: 9802369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
    Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
    Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.
    Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q
    Am J Respir Cell Mol Biol; 1997 Jul; 17(1):17-24. PubMed ID: 9224205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge.
    Rak S; Jacobson MR; Sudderick RM; Masuyama K; Juliusson S; Kay AB; Hamid Q; Löwhagen O; Durham SR
    Clin Exp Allergy; 1994 Oct; 24(10):930-9. PubMed ID: 7842362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of IL-4, Cepsilon RNA, and Iepsilon RNA in the nasal mucosa of patients with seasonal rhinitis: effect of topical corticosteroids.
    Cameron LA; Durham SR; Jacobson MR; Masuyama K; Juliusson S; Gould HJ; Lowhagen O; Minshall EM; Hamid QA
    J Allergy Clin Immunol; 1998 Mar; 101(3):330-6. PubMed ID: 9525448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo expression of signal transducer and activator of transcription factor 6 (STAT6) in nasal mucosa from atopic allergic rhinitis: effect of topical corticosteroids.
    Ghaffar O; Christodoulopoulos P; Lamkhioued B; Wright E; Ihaku D; Nakamura Y; Frenkiel S; Hamid Q
    Clin Exp Allergy; 2000 Jan; 30(1):86-93. PubMed ID: 10606935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia.
    Durham SR; Ying S; Varney VA; Jacobson MR; Sudderick RM; Mackay IS; Kay AB; Hamid QA
    J Immunol; 1992 Apr; 148(8):2390-4. PubMed ID: 1560199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
    Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
    Erin EM; Zacharasiewicz AS; Nicholson GC; Tan AJ; Higgins LA; Williams TJ; Murdoch RD; Durham SR; Barnes PJ; Hansel TT
    Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive treatment of intranasal fluticasone propionate reduces cytokine mRNA expressing cells before and during a single nasal allergen provocation.
    Kleinjan A; Holm AF; Dijkstra MD; Boks SS; Severijnen L; Mulder PG; Fokkens WJ
    Clin Exp Allergy; 2000 Oct; 30(10):1476-85. PubMed ID: 10998026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid.
    Bradding P; Feather IH; Wilson S; Holgate ST; Howarth PH
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1900-6. PubMed ID: 7767538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment.
    Laberge S; Durham SR; Ghaffar O; Rak S; Center DM; Jacobson M; Hamid Q
    J Allergy Clin Immunol; 1997 Oct; 100(4):569-74. PubMed ID: 9338554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics.
    Broide DH; Paine MM; Firestein GS
    J Clin Invest; 1992 Oct; 90(4):1414-24. PubMed ID: 1401075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Hamilos DL; Leung DY; Wood R; Meyers A; Stephens JK; Barkans J; Meng Q; Cunningham L; Bean DK; Kay AB
    J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):39-48. PubMed ID: 8335853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate effect of topical budesonide on allergen challenge-induced nasal mucosal fluid levels of granulocyte-macrophage colony-stimulating factor and interleukin-5.
    Linden M; Svensson C; Andersson E; Andersson M; Greiff L; Persson CG
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1705-8. PubMed ID: 11069800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in IL-8, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation.
    KleinJan A; Dijkstra MD; Boks SS; Severijnen LA; Mulder PG; Fokkens WJ
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):441-50. PubMed ID: 10069878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluticasone propionate reduced the production of GM-CSF, IL-6 and IL-8 generated from cultured nasal epithelial cells].
    Ohnishi M; Takizawa R; Ohkubo K; Yokosima K; Okuda M; Yagi T
    Arerugi; 1994 Mar; 43(3):441-7. PubMed ID: 8198453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis.
    Linden M; Svensson C; Andersson M; Greiff L; Andersson E; Denburg JA; Persson CG
    Allergy; 1999 Mar; 54(3):212-9. PubMed ID: 10321556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.